Global Humanised Mouse and Rat Model Market Report and Forecast 2024-2032

Global Humanised Mouse and Rat Model Market Outlook

The global humanised mouse and rat model market reached a value of more than USD 128.49 million in 2023. The industry is further expected to grow at a CAGR of about 10.1% in the forecast period of 2024-2032 to reach a value of over USD 306.63 million by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America and the Asia pacific to Significantly Aid the Humanised Mouse and Rat Model Industry

North America represents one of the leading regions in the global market for humanised mouse and rat model. This can be attributed to growing biomedical research, preclinical activities by CROs and pharmaceutical research and development, continued and responsible use of animals ensured by animal care organisations, increasing monoclonal antibody production in the United States. This, along with the growing stem cell research, and government support and initiatives for the development of protein drugs in Canada, is contributing to the market growth. Additionally, the growing number of investments by the government for the development of innovations in mouse models is spurring market growth. In addition to this, the rising focus by leading market players on market development strategies is positively influencing the growth of the regional market.

Meanwhile, the Asia Pacific region, too, occupies a considerable share in the market due to international alliances for research and development activities in China, initiatives to reduce drug approval time, mandatory animal testing for all pharmaceutical drugs and cosmetics in China, increasing government and private sector investments in life sciences sector, growing consumer demand, and growing biomedical and medical research. In addition to this, research in regenerative medicine in Japan, and the overall flourishing healthcare system of Japan is propelling the growth in the Asia Pacific region. Furthermore, the growth of the biomedical industry in India, development of bio-clusters to boost India’s biotechnology, growth in translational and biomedical research in different countries of the Asia Pacific region is expanding the growth of the market. These trends are likely to continue in the forecast period as well and contribute to the market growth.

Humanised Mouse and Rat Model: Market Segmentation

In biology and medical research, a humanised mouse and rat model is a model that comprises functional human genes, cells, tissues, and organs. These mouse and rat models are utilised to simulate a human immune system in both healthy and diseased situations.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

By type, the market is divided into:

• Humanised Mouse Models
  • Cell-based Humanised Mouse Model
    • CD34
    • PBMC
    • BLT
  • Genetic Humanised Mouse Model
• Humanised Rat Models

The market based on application, can be classified into:

• Oncology
• Immunology and Infectious Diseases
• Neuroscience
• Haematopoiesis
• Toxicology
• Others

Based on end use, the market can be categorised into:

• Pharmaceutical and Biotechnology Companies
• Contract Research Organisations
• Academic and Research Institutions

The EMR report looks into the regional markets for humanised mouse and rat model like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

_{Rising Demand for Personalised Medicine Boosting the Market Growth}

Due to the growing demand for personalised medication, the market for humanised mouse and rat model is likely to grow at a significant pace during the forecast period, as these medicines are designed using animal models, particularly mice models. In order to determine the most appropriate therapy, the model is treated with a variety of medications or gene therapies, resulting in personalised medication for patients, thereby propelling the market growth. The growth of the market can further be determined by the increasing number of research activities involving humanised models, in pharmaceutical and biotechnology companies, technological developments, use of mouse and rat models for the detection of immunodeficiency disorders, tumours, and other unusual diseases.

Furthermore, the market is expected to be aided by rising applications of the model in cancer research activities, and increasing innovation to develop humanised mouse models tailored to meet the specific needs of cancer research. The growth of humanised mouse model industry can also be attributed to the rising incidences of chronic disorders and growing demand for efficient therapeutic drugs, which is anticipated to bring new opportunities. As a result, the rapidly flourishing medical industry around the world is boosting the market growth of humanised mouse and rat model.

Key Industry Players in the  Global Humanised Mouse and Rat Model Market

The report gives a detailed analysis of the following key players in the global humanised mouse and rat model market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• The Jackson Laboratory
• GenOway S.A.
• TransGenic Inc.
• Horizon Discovery Group plc
• Vitalstar Biotechnology Co., Ltd.
• Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report